These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 798190)

  • 41. A comparison of chlorprothixene and haloperidol in acute schizophrenia.
    Marjerrison G; Bowman R; Keogh RP
    Can Psychiatr Assoc J; 1971 Dec; 16(6):533-6. PubMed ID: 4947173
    [No Abstract]   [Full Text] [Related]  

  • 42. Butaclamol hydrochloride in newly admitted schizophrenics.
    Hollister LE; Davis KL; Berger PA
    Psychopharmacol Commun; 1975; 1(5):493-500. PubMed ID: 778939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of chronic schizophrenia with cyproheptadine.
    Silver H; Blacker M; Weller MP; Lerer B
    Biol Psychiatry; 1989 Feb; 25(4):502-4. PubMed ID: 2649160
    [No Abstract]   [Full Text] [Related]  

  • 44. Rehabilitation of the chronic patient: experience in the USA.
    Howard JS
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):41-5. PubMed ID: 798189
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients.
    Davidson M; Harvey PD; Bergman RL; Powchik P; Kaminsky R; Losonczy MF; Davis KL
    Arch Gen Psychiatry; 1990 Feb; 47(2):190-1. PubMed ID: 2405808
    [No Abstract]   [Full Text] [Related]  

  • 46. Acutely administered haloperidol has little effect on steady-state visual evoked potentials from pattern-reversal stimulations in treated schizophrenics.
    Jibiki I; Kurokawa K; Fukushima T; Yamaguchi N
    Jpn J Psychiatry Neurol; 1993 Mar; 47(1):51-5. PubMed ID: 8411790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Updating haloperidol: 1975].
    Ayd FJ
    Acta Physiol Lat Am; 1978 Sep; 24(3):233-8. PubMed ID: 751446
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics.
    Rompel H; Segal H
    J Int Med Res; 1978; 6(2):126-32. PubMed ID: 344086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential drug effects identified by 3-way configural frequency analysis.
    Lienert GA; Lehmann E
    Neuropsychobiology; 1984; 11(4):247-50. PubMed ID: 6493479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment.
    Galderisi S; Mucci A; Di Gregorio MR; Bucci P; Maj M; Kemali D
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):51-4. PubMed ID: 2136214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
    Tsuang MM; Lu LM; Stotsky BA; Cole JO
    J Am Geriatr Soc; 1971 Jul; 19(7):593-600. PubMed ID: 4937658
    [No Abstract]   [Full Text] [Related]  

  • 52. Changes in staff anxiety and attitudes during a double blind study of haloperidol in acute schizophrenics within a structured milieu.
    Singh MM; Di Scipio WJ
    J Nerv Ment Dis; 1972 Oct; 155(4):245-56. PubMed ID: 4561348
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies on the treatment of chronic simple schizophrenia with haloperidol].
    Kaczyński M; Bernaśkiewicz E; Wypych M; Wojnicka H
    Neurol Neurochir Psychiatr Pol; 1965; 15(2):281-7. PubMed ID: 5320012
    [No Abstract]   [Full Text] [Related]  

  • 54. Vitamin C in the treatment of schizophrenia.
    Sandyk R; Kanofsky JD
    Int J Neurosci; 1993 Jan; 68(1-2):67-71. PubMed ID: 8063516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of parenteral administration of haloperidol in man. II. Male chronic schizophrenics: quantitative EEG findings.
    Pfeiffer CC; Goldstein L; Sugerman AA
    J Clin Pharmacol J New Drugs; 1968; 8(2):89-94. PubMed ID: 5240367
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluating the effects of drugs on behavior and quality of life: an alternative strategy for clinical trials.
    Bagne CA; Lewis RF
    J Consult Clin Psychol; 1992 Apr; 60(2):225-39. PubMed ID: 1592952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose haloperidol increases CSF opioid activity in patients with chronic schizophrenia.
    Rimón R; Terenius L; Averbuch I; Belmaker RH
    Pharmacopsychiatria; 1983 Jan; 16(1):9-12. PubMed ID: 6828553
    [No Abstract]   [Full Text] [Related]  

  • 58. Assessment of low dosage haloperidol in anxiety states.
    Rogerson R; Butler JK
    Br J Psychiatry; 1971 Aug; 119(549):169-70. PubMed ID: 4935699
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of chronic schizophrenic patients.
    Jones B
    J Clin Psychopharmacol; 1988 Aug; 8(4):301-3. PubMed ID: 3209727
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pancytopenia].
    Stockmeyer M
    Praxis (Bern 1994); 2000 Oct; 89(42):1717-8. PubMed ID: 11105613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.